Antimicrobial Updates for Primary Care: A Pharmacotherapy Focus
- Speaker:
- Eric Wombwell, PharmD, BCIDP
- Duration:
- 2 Hours 01 Minutes
- Format:
- Audio and Video
- Copyright:
-
May 15, 2025
- Product Code:
- POS078943
- Media Type:
- Digital Seminar
Description
This engaging and practical session, “Antimicrobial Updates for Primary Care: A Pharmacotherapy Focus,” led by Dr. Eric Wombwell, a board-certified infectious disease pharmacist and clinical professor, will provide practitioners with the latest evidence-based strategies for managing common infectious diseases in the primary care setting. The presentation will delve into critical updates regarding penicillin allergies, differentiating true allergies from intolerances to ensure appropriate beta-lactam use. Dr. Wombwell will also review current treatment guidelines for community-acquired pneumonia, considering comorbidities and antibiotic resistance, and provide a review of Clostridioides difficile infection, including the use of recently approved fecal microbiota products.
A significant portion of the session will be dedicated to urinary tract infections, covering first-line treatment options, the increasing role of fosfomycin and nitrofurantoin in the face of evolving resistance trends, new antibiotic approvals, and emerging guidance from WikiGuidelines and anticipated IDSA recommendations. The session will also address skin infections, including appropriate antibiotic choices and MRSA coverage, and recap the 2023 diabetic foot infection recommendations. Through case-based discussions and practical application of current guidelines, participants will enhance their ability to optimize antimicrobial prescribing, minimize adverse effects, and contribute to antimicrobial stewardship efforts.
Credit
Handouts/Brochure
| File type | File name | Number of pages | |
|---|---|---|---|
| Manual - Antimicrobial Updates for Primary Care (3.4 MB) | 69 Pages | Available after Purchase |
Speaker
Eric Wombwell, PharmD, BCIDP Related seminars and products
Dr. Eric Wombwell is a board-certified infectious diseases pharmacist and clinical associate professor for the Department of Pharmacy Practice and Administration at the University of Missouri – Kansas City, School of Pharmacy. Eric completed his PharmD degree at the University of Missouri Kansas City, followed by an ASHP accredited pharmacy practice residency at the Kansas City VA Medical Center. Following residency, he accepted a full-time non-tenured clinical faculty position at the University of Missouri – Kansas City, School of Pharmacy. His teaching responsibilities include infectious diseases topics throughout the curriculum. Eric also has a clinical appointment at Centerpoint Medical Center rounding with the infectious diseases consult team and supporting antimicrobial stewardship efforts at the facility.
Eric is regularly published in pharmacy and infectious diseases research and is frequently invited to deliver continuing education presentations locally and nationally to various health-professional audiences. He is recognized for excellence in teaching through various awards, including the “Missouri Pharmacist Association – UMKC Faculty Member of the Year”, and the “University of Missouri – Kansas City Provost’s Award for Excellence in Teaching”.
Speaker Disclosures:
Financial: Eric Wombwell has an employment relationship with the University of Missouri. He receives a speaking honorarium, recording royalties, and a consulting fee from PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Eric Wombwell is a member of the Society of Infectious Diseases Pharmacists, the Missouri Pharmacists Association, American Association of Colleges of Pharmacy, Infectious Diseases Society of America, and Centerpoint Medical Center.
Additional Info
Access for Self-Study (Non-Interactive)Access never expires for this product.
Questions?
Visit our FAQ page at www.pesi.com/faq or contact us at www.pesi.com/info
Objectives
- Apply appropriate strategies for antibiotic selection in patients with reported penicillin allergies, minimizing unnecessary avoidance of beta-lactam antibiotics.
- Synthesize recent data on UTI treatment, including resistance trends, new antibiotic approvals, and emerging consensus guidelines to optimize patient care.
- Choose effective antibiotic therapies that minimize risk for adverse effects.
- Implement strategies to optimize antimicrobial prescribing, contributing to antimicrobial stewardship efforts and minimizing the development of resistance.
Outline
Penicillin Allergies- Manage patients with antibiotic allergies
- Distinguish between true allergies and intolerances
- Current treatment guidelines
- Considerations for comorbidities and antibiotic resistance
- Up-to-date guidelines for pharmacological treatments
- Considerations for recently approved fecal microbiota products
- Fist-line treatment options, including considerations for local resistance patterns
- Increase role of fosfomycin and nitrofurantoin
- Recent resistance trends
- New antibiotic approvals
- Highlight WikiGuidelines Group Consensus guidance and expected IDSA recommendations
- Appropriate antibiotic choices, including coverage for MRSA when indicated
- Recap on the 2023 Diabetic Foot Infection recommendations
Target Audience
- NPs
- APRNs
- PAs
- PharmDs
- MDs
- DOs
Reviews
Satisfaction Guarantee
Your satisfaction is our goal and our guarantee. Concerns should be addressed to: PO Box 1000, Eau Claire, WI 54702-1000 or call 1-800-844-8260.
ADA Needs
We would be happy to accommodate your ADA needs; please call our Customer Service Department for more information at 1-800-844-8260.
PESI Mobile App
Access CE trainings on your phone or tablet through our free mobile app. Choose video or audio-only versions of online courses from the world’s best instructors, and complete your CE requirements anywhere, anytime, at your own pace.
Please wait ...